Neurogene Inc.

SEC 4 · Filed

0001606302-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Feb 20, 2026

Grant, award or other acquisition by McMinn Rachel

Security
Stock Option (Right to Buy)
Code
A
Shares
155,100
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-20",
  "direction": "A",
  "exercise_price": "17.64",
  "expiration": "2036-02-20",
  "footnotes": {
    "F3": "This option represents the right to purchase 155,100 shares of the Issuer\u0027s common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person\u0027s continued provision of service to the Issuer on each vesting date."
  },
  "owners": [
    {
      "cik": "0001606302",
      "name": "McMinn Rachel",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "155100",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (Right to Buy)",
  "shares": "155100",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "155100"
}
Insider transactionsEvent date Feb 20, 2026

Grant, award or other acquisition by McMinn Rachel

Security
Common Stock
Code
A
Shares
25,900
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-02-20",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Consist of 25,900 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person\u0027s continued provision of services to the Issuer on each vesting date.",
    "F2": "Includes (a) 23,900 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (b) 25,900 restricted stock units granted on February 20, 2029, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029. Due to an administrative error, the amount reported in Column 5 on the Reporting Person\u0027s Form 4 filed on March 28, 2025 was understated by the 47,500 shares reported as purchased by the Reporting Person on the Reporting Person\u0027s Form 4 filed on November 25, 2024. This Form 4 reflects the correct amount of common stock beneficially owned by the Reporting Person."
  },
  "owners": [
    {
      "cik": "0001606302",
      "name": "McMinn Rachel",
      "roles": [
        "director",
        "officer"
      ],
      "title": "Chief Executive Officer"
    }
  ],
  "ownership": "D",
  "post_shares": "1347659",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "25900",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}